Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Burcu Pervin"'
Autor:
Burcu Pervin, Merve Gizer, Mehmet Emin Şeker, Özgür Doğuş Erol, Sema Nur Gür, Ece Gizem Polat, Bahar Değirmenci, Petek Korkusuz, Fatima Aerts‐Kaya
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 5, Pp n/a-n/a (2024)
Abstract Inflammatory bowel disease (IBD) is characterized by a chronically dysregulated immune response in the gastrointestinal tract. Bone marrow multipotent mesenchymal stromal cells have an important immunomodulatory function and support regenera
Externí odkaz:
https://doaj.org/article/328362d20c6e459aa96a1636f9f7dde9
Autor:
Özgür Dogus Erol, Burcu Pervin, Mehmet Emin Şeker, Burcu Özçimen, Şimal Şenocak, Sema Nur Gür, Hasan Basri Kiliç, Merve Gizer, Petek Korkusuz, Nico Peter van Til, Yusuf Çetin Kocaefe, Fatima Aerts Kaya
Publikováno v:
HemaSphere, Vol 7, p e37198af (2023)
Externí odkaz:
https://doaj.org/article/a0c1f33184514a73ad55aa4b5356ba3a
Autor:
Mehmet Emİn Şeker, Özgür Doğuş Erol, Burcu Pervİn, Gerard Wagemaker, Nico Peter VAN Til, Fatima Aerts-Kaya
Publikováno v:
HemaSphere, Vol 7, p e6316019 (2023)
Externí odkaz:
https://doaj.org/article/d90911c59fc34f36a9d789872ffe8480
Autor:
Gülen Güney-Esken, Özgür Doğuş Erol, Burcu Pervin, Gülben Gürhan Sevinç, Tamer Önder, Elif Bilgiç, Petek Korkusuz, Ayşen Günel-Özcan, Duygu Uçkan-Çetinkaya, Fatima Aerts-Kaya
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Abstract Background Griscelli syndrome type 2 (GS-2) is a rare, autosomal recessive immune deficiency syndrome caused by a mutation in the RAB27A gene, which results in the absence of a protein involved in vesicle trafficking and consequent loss of f
Externí odkaz:
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
Publikováno v:
World Journal of Stem Cells
Despite a vast amount of different methods, protocols and cryoprotective agents (CPA), stem cells are often frozen using standard protocols that have been optimized for use with cell lines, rather than with stem cells. Relatively few comparative stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8817137fcdab29e57b7af38326a1525
http://europepmc.org/articles/PMC8474714
http://europepmc.org/articles/PMC8474714
Autor:
Gülben Gürhan Sevinç, Elif Bilgiç, Özgür Doğuş Erol, Fatima Aerts-Kaya, Aysen Gunel-Ozcan, Tamer T. Onder, Duygu Uckan-Cetinkaya, Burcu Pervin, Petek Korkusuz, Gülen Güney-Esken
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background: Griscelli syndrome type 2 (GS-2) is a rare, autosomal recessive immune deficiency syndrome caused by a mutation in the RAB27A gene, which results in the absence of a protein involved in vesicle trafficking and consequent loss of function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b4da836eb8f9bd97526e935d04be45
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
Publikováno v:
International Journal of Hematology. 113:5-9
In recent years, multipotent mesenchymal stromal cells (MSCs) have demonstrated tremendous potential for use in regenerative medicine. CXCR4, the receptor for CXCL12, is highly expressed by bone marrow (BM) MSCs and the CXCR4/CXCL12 axis has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af9d3be098565296204082c08633d228
https://doi.org/10.1007/s12185-020-03043-0
https://doi.org/10.1007/s12185-020-03043-0
Autor:
Özgür Özyüncü, F. Duygu Uçkan-Çetinkaya, Aynura Mammadova, Fatima Aerts-Kaya, Gerard Wagemaker, Trudi P. Visser, Burcu Pervin
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:634-642
The newly developed 6-hydroxychromanol derivate SUL-109 was shown to provide protection during hypothermic storage of several cell lines, but has not been evaluated in hematopoietic stem cells (HSCs). Hypothermic preservation of HSCs would be preferr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635be5b890ea6f067a0c8f5e94728169
https://doi.org/10.1016/j.bbmt.2019.12.770
https://doi.org/10.1016/j.bbmt.2019.12.770
Publikováno v:
International journal of hematology. 113(1)
In recent years, multipotent mesenchymal stromal cells (MSCs) have demonstrated tremendous potential for use in regenerative medicine. CXCR4, the receptor for CXCL12, is highly expressed by bone marrow (BM) MSCs and the CXCR4/CXCL12 axis has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cbf5579ee50497e19602e4114dc40e54
https://pubmed.ncbi.nlm.nih.gov/33389659
https://pubmed.ncbi.nlm.nih.gov/33389659
Autor:
Fatima Aerts-Kaya, Axel Schambach, Gulen Guney, Duygu Uckan-Cetinkaya, Aysen Gunel-Ozcan, Burcu Pervin, Ozge Burcu Sahan
Publikováno v:
Experimental Hematology. 53:S135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f63ccaf52779ccd9992afb6689182a7a
https://doi.org/10.1016/j.exphem.2017.06.344
https://doi.org/10.1016/j.exphem.2017.06.344